DOCSLIB.ORG

Rabbit Anti-Junctophilin 1/FITC Conjugated Antibody

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rabbit Anti-Junctophilin 1/FITC Conjugated Antibody SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-Junctophilin 1/FITC Conjugated antibody SL17209R-FITC Product Name: Anti-Junctophilin 1/FITC Chinese Name: FITC标记的亲联蛋白1抗体 DKFZp762L0313; JP 1; JP1; JPH 1; JPH1; Junctophilin 1; Junctophilin type 1; Alias: Junctophilin type1; Junctophilin1; Mitsugumin 72; Mitsugumin72. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Dog,Pig,Cow,Horse,Rabbit,Sheep, ICC=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 72kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human Junctophilin 1 Lsotype: IgG Purification: affinitywww.sunlongbiotech.com purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk Product Detail: between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. [provided by RefSeq, Jul 2008] Function: JPH1 (Junctophilin 1) contributes to the stabilization of junctional membrane complexes, which are a common feature of all excitable cells and mediate cross talk between the cell surface and intracellular ion channels. It may act by anchoring the plasma membrane and endoplasmic/sarcoplasmic reticulum (ER/SR). It is composed of a C terminal hydrophobic segment spanning the ER/SR membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. Subcellular Location: Cell membrane; Peripheral membrane protein (By similarity). Endoplasmic reticulum membrane; Single pass type IV membrane protein (By similarity). Sarcoplasmic reticulum membrane; Single pass type IV membrane protein. Note: Localized predominantly on the plasma membrane. The transmembrane domain is anchored in endoplasmic/sarcoplasmic reticulum membrane, while the N terminal part associates with the plasma membrane. In skeletal muscle cells, it is predominantly localized at the junction of the A and I bands. Database links: Entrez Gene: 56704 Human Omim: 605266 Human SwissProt: Q9HDC5 Human Unigene: 657367 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeuticwww.sunlongbiotech.com or diagnostic applications. .
Load more

Recommended publications
  • Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence After Radical Prostatectomy
    Int. J. Mol. Sci. 2015, 16, 3856-3869; doi:10.3390/ijms16023856 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy Chinyere Ibeawuchi 1, Hartmut Schmidt 2, Reinhard Voss 3, Ulf Titze 4, Mahmoud Abbas 5, Joerg Neumann 6, Elke Eltze 7, Agnes Marije Hoogland 8, Guido Jenster 9, Burkhard Brandt 10 and Axel Semjonow 1,* 1 Prostate Center, Department of Urology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany; E-Mail: [email protected] 2 Center for Laboratory Medicine, University Hospital Muenster, Albert-Schweitzer-Campus 1, Gebaeude 1A, Muenster D-48149, Germany; E-Mail: [email protected] 3 Interdisciplinary Center for Clinical Research, University of Muenster, Albert-Schweitzer-Campus 1, Gebaeude D3, Domagkstrasse 3, Muenster D-48149, Germany; E-Mail: [email protected] 4 Pathology, Lippe Hospital Detmold, Röntgenstrasse 18, Detmold D-32756, Germany; E-Mail: [email protected] 5 Institute of Pathology, Mathias-Spital-Rheine, Frankenburg Street 31, Rheine D-48431, Germany; E-Mail: [email protected] 6 Institute of Pathology, Klinikum Osnabrueck, Am Finkenhuegel 1, Osnabrueck D-49076, Germany; E-Mail: [email protected] 7 Institute of Pathology, Saarbrücken-Rastpfuhl, Rheinstrasse 2, Saarbrücken D-66113, Germany; E-Mail: [email protected] 8 Department
    [Show full text]
  • A Multi-Stage Genome-Wide Association Study of Uterine Fibroids in African Americans
    UCLA UCLA Previously Published Works Title A multi-stage genome-wide association study of uterine fibroids in African Americans. Permalink https://escholarship.org/uc/item/0mc5r0xh Journal Human genetics, 136(10) ISSN 0340-6717 Authors Hellwege, Jacklyn N Jeff, Janina M Wise, Lauren A et al. Publication Date 2017-10-01 DOI 10.1007/s00439-017-1836-1 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Hum Genet (2017) 136:1363–1373 DOI 10.1007/s00439-017-1836-1 ORIGINAL INVESTIGATION A multi‑stage genome‑wide association study of uterine fbroids in African Americans Jacklyn N. Hellwege1,2,3 · Janina M. Jef4 · Lauren A. Wise5,6 · C. Scott Gallagher7 · Melissa Wellons8,9 · Katherine E. Hartmann3,9 · Sarah F. Jones1,3 · Eric S. Torstenson1,2 · Scott Dickinson10 · Edward A. Ruiz‑Narváez6 · Nadin Rohland7 · Alexander Allen7 · David Reich7,11,12 · Arti Tandon7 · Bogdan Pasaniuc13,14 · Nicholas Mancuso13 · Hae Kyung Im10 · David A. Hinds15 · Julie R. Palmer6 · Lynn Rosenberg6 · Joshua C. Denny16,17 · Dan M. Roden2,16,17,18 · Elizabeth A. Stewart19 · Cynthia C. Morton12,20,21,22 · Eimear E. Kenny4 · Todd L. Edwards1,2,3 · Digna R. Velez Edwards2,3,9 Received: 12 April 2017 / Accepted: 16 August 2017 / Published online: 23 August 2017 © Springer-Verlag GmbH Germany 2017 Abstract Uterine fbroids are benign tumors of the uterus imaging, genotyped and imputed to 1000 Genomes. Stage 2 afecting up to 77% of women by menopause. They are the used self-reported fbroid and GWAS data from 23andMe, leading indication for hysterectomy, and account for $34 bil- Inc.
    [Show full text]
  • Identification of Novel Chemotherapeutic Strategies For
    www.nature.com/scientificreports OPEN Identification of novel chemotherapeutic strategies for metastatic uveal melanoma Received: 17 November 2016 Paolo Fagone1, Rosario Caltabiano2, Andrea Russo3, Gabriella Lupo1, Accepted: 09 February 2017 Carmelina Daniela Anfuso1, Maria Sofia Basile1, Antonio Longo3, Ferdinando Nicoletti1, Published: 17 March 2017 Rocco De Pasquale4, Massimo Libra1 & Michele Reibaldi3 Melanoma of the uveal tract accounts for approximately 5% of all melanomas and represents the most common primary intraocular malignancy. Despite improvements in diagnosis and more effective local therapies for primary cancer, the rate of metastatic death has not changed in the past forty years. In the present study, we made use of bioinformatics to analyze the data obtained from three public available microarray datasets on uveal melanoma in an attempt to identify novel putative chemotherapeutic options for the liver metastatic disease. We have first carried out a meta-analysis of publicly available whole-genome datasets, that included data from 132 patients, comparing metastatic vs. non metastatic uveal melanomas, in order to identify the most relevant genes characterizing the spreading of tumor to the liver. Subsequently, the L1000CDS2 web-based utility was used to predict small molecules and drugs targeting the metastatic uveal melanoma gene signature. The most promising drugs were found to be Cinnarizine, an anti-histaminic drug used for motion sickness, Digitoxigenin, a precursor of cardiac glycosides, and Clofazimine, a fat-soluble iminophenazine used in leprosy. In vitro and in vivo validation studies will be needed to confirm the efficacy of these molecules for the prevention and treatment of metastatic uveal melanoma. Uveal melanoma is the most common primary intraocular cancer, and after the skin, the uveal tract is the second most common location for melanoma1.
    [Show full text]
  • Identifying C-Mannosylatedproteins in RAW264.7 Cells Via in Vitro HSC70 Co-Immunoprecipitation Strategies Nicholas Ryan Kegley [email protected]
    Marshall University Marshall Digital Scholar Theses, Dissertations and Capstones 2019 Identifying C-mannosylatedproteins in RAW264.7 cells via in vitro HSC70 Co-immunoprecipitation strategies Nicholas Ryan Kegley [email protected] Follow this and additional works at: https://mds.marshall.edu/etd Part of the Biochemistry Commons, and the Chemistry Commons Recommended Citation Kegley, Nicholas Ryan, "Identifying C-mannosylatedproteins in RAW264.7 cells via in vitro HSC70 Co-immunoprecipitation strategies" (2019). Theses, Dissertations and Capstones. 1217. https://mds.marshall.edu/etd/1217 This Thesis is brought to you for free and open access by Marshall Digital Scholar. It has been accepted for inclusion in Theses, Dissertations and Capstones by an authorized administrator of Marshall Digital Scholar. For more information, please contact [email protected], [email protected]. IDENTIFYING C-MANNOSYLATED PROTEINS IN RAW264.7 CELLS VIA IN VITRO HSC70 CO-IMMUNOPRECIPITATION STRATEGIES A thesis submitted to the Graduate College of Marshall University In Partial fulfillment of the requirements for the degree of Master of Science In Chemistry By Nicholas Ryan Kegley Approved by Dr. John F. Rakus, Committee Chairperson Dr. Derrick R. J. Kolling Dr. Elmer J. Price Marshall University May 2019 APPROVAL OF THESIS We, the faculty supervising the work of Nicholas Ryan Kegley, affirm that the thesis, Identifying C-mannosylated Proteins in RAW264.7 Cells via In Vitro Hsc70 Co-Immunoprecipitation Strategies, meets the high academic standards for original scholarship and creative work established by the Chemistry Program and the College of Science. This work also conforms to the editorial standards of our discipline and the Graduate College of Marshall University.
    [Show full text]
  • Molecular Composition and Pharmacology of Store-Operated Calcium Entry in Sensory Neurons
    Molecular composition and pharmacology of store-operated calcium entry in sensory neurons Alexandra-Silvia Hogea Submitted in accordance with the requirements for the degree of Doctor of Philosophy The University of Leeds School of Biomedical Sciences September 2018 The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Alexandra -Silvia Hogea to be identified as Author of this work has been asserted by in accordance with the Copyright, Designs and Patents Act 1988. ii Acknowledgements Firstly, I would like to express my appreciation and thanks to my supervisor, mentor and friend, Professor Nikita Gamper. It has been an amazing time and even if it was filled with challenges, I overcame them thanks to your continued support, guidance and optimism. I am extremely grateful to Professor David Beech and Dr. Lin Hua Jiang for their guidance at different stages during my early PhD years. I am very lucky to have met past and present Gamper lab members who contributed greatly to my development as a scientist, who welcomed me in their lives and made Leeds feel more like home. A massive thank you to Shihab Shah for the support and friendship, for being patient during hard times and for celebrating the achievements together. It has been quite a ride! I would also like to express my gratitude to Ewa Jaworska who first introduced me to immunohistochemistry at times when I thought nail polish is just for nails.
    [Show full text]
  • Late First Trimester Circulating Microparticle Proteins Predict The
    www.nature.com/scientificreports OPEN Late frst trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic diferences among afected cases Thomas F. McElrath1*, David E. Cantonwine1, Kathryn J. Gray1, Hooman Mirzakhani2, Robert C. Doss3, Najmuddin Khaja3, Malik Khalid3, Gail Page3, Brian Brohman3, Zhen Zhang4, David Sarracino6 & Kevin P. Rosenblatt3,5 We hypothesize that frst trimester circulating micro particle (CMP) proteins will defne preeclampsia risk while identifying clusters of disease subtypes among cases. We performed a nested case–control analysis among women with and without preeclampsia. Cases diagnosed < 34 weeks’ gestation were matched to controls. Plasma CMPs were isolated via size exclusion chromatography and analyzed using global proteome profling based on HRAM mass spectrometry. Logistic models then determined feature selection with best performing models determined by cross-validation. K-means clustering examined cases for phenotypic subtypes and biological pathway enrichment was examined. Our results indicated that the proteins distinguishing cases from controls were enriched in biological pathways involved in blood coagulation, hemostasis and tissue repair. A panel consisting of C1RL, GP1BA, VTNC, and ZA2G demonstrated the best distinguishing performance (AUC of 0.79). Among the cases of preeclampsia, two phenotypic sub clusters distinguished cases; one enriched for platelet degranulation and blood coagulation pathways and the other for complement and immune response- associated pathways (corrected p < 0.001). Signifcantly, the second of the two clusters demonstrated lower gestational age at delivery (p = 0.049), increased protein excretion (p = 0.01), more extreme laboratory derangement (p < 0.0001) and marginally increased diastolic pressure (p = 0.09). We conclude that CMP-associated proteins at 12 weeks’ gestation predict the overall risk of developing early preeclampsia and indicate distinct subtypes of pathophysiology and clinical morbidity.
    [Show full text]
  • An Expanded Proteome of Cardiac T-Tubules☆
    Cardiovascular Pathology 42 (2019) 15–20 Contents lists available at ScienceDirect Cardiovascular Pathology Original Article An expanded proteome of cardiac t-tubules☆ Jenice X. Cheah, Tim O. Nieuwenhuis, Marc K. Halushka ⁎ Department of Pathology, Division of Cardiovascular Pathology, Johns Hopkins University SOM, Baltimore, MD, USA article info abstract Article history: Background: Transverse tubules (t-tubules) are important structural elements, derived from sarcolemma, found Received 27 February 2019 on all striated myocytes. These specialized organelles create a scaffold for many proteins crucial to the effective Received in revised form 29 April 2019 propagation of signal in cardiac excitation–contraction coupling. The full protein composition of this region is un- Accepted 17 May 2019 known. Methods: We characterized the t-tubule subproteome using 52,033 immunohistochemical images covering Keywords: 13,203 proteins from the Human Protein Atlas (HPA) cardiac tissue microarrays. We used HPASubC, a suite of Py- T-tubule fi Proteomics thon tools, to rapidly review and classify each image for a speci c t-tubule staining pattern. The tools Gene Cards, Caveolin String 11, and Gene Ontology Consortium as well as literature searches were used to understand pathways and relationships between the proteins. Results: There were 96 likely t-tubule proteins identified by HPASubC. Of these, 12 were matrisome proteins and 3 were mitochondrial proteins. A separate literature search identified 50 known t-tubule proteins. A comparison of the 2 lists revealed only 17 proteins in common, including 8 of the matrisome proteins. String11 revealed that 94 of 127 combined t-tubule proteins generated a single interconnected network. Conclusion: Using HPASubC and the HPA, we identified 78 novel, putative t-tubule proteins and validated 17 within the literature.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • Table S1. 103 Ferroptosis-Related Genes Retrieved from the Genecards
    Table S1. 103 ferroptosis-related genes retrieved from the GeneCards. Gene Symbol Description Category GPX4 Glutathione Peroxidase 4 Protein Coding AIFM2 Apoptosis Inducing Factor Mitochondria Associated 2 Protein Coding TP53 Tumor Protein P53 Protein Coding ACSL4 Acyl-CoA Synthetase Long Chain Family Member 4 Protein Coding SLC7A11 Solute Carrier Family 7 Member 11 Protein Coding VDAC2 Voltage Dependent Anion Channel 2 Protein Coding VDAC3 Voltage Dependent Anion Channel 3 Protein Coding ATG5 Autophagy Related 5 Protein Coding ATG7 Autophagy Related 7 Protein Coding NCOA4 Nuclear Receptor Coactivator 4 Protein Coding HMOX1 Heme Oxygenase 1 Protein Coding SLC3A2 Solute Carrier Family 3 Member 2 Protein Coding ALOX15 Arachidonate 15-Lipoxygenase Protein Coding BECN1 Beclin 1 Protein Coding PRKAA1 Protein Kinase AMP-Activated Catalytic Subunit Alpha 1 Protein Coding SAT1 Spermidine/Spermine N1-Acetyltransferase 1 Protein Coding NF2 Neurofibromin 2 Protein Coding YAP1 Yes1 Associated Transcriptional Regulator Protein Coding FTH1 Ferritin Heavy Chain 1 Protein Coding TF Transferrin Protein Coding TFRC Transferrin Receptor Protein Coding FTL Ferritin Light Chain Protein Coding CYBB Cytochrome B-245 Beta Chain Protein Coding GSS Glutathione Synthetase Protein Coding CP Ceruloplasmin Protein Coding PRNP Prion Protein Protein Coding SLC11A2 Solute Carrier Family 11 Member 2 Protein Coding SLC40A1 Solute Carrier Family 40 Member 1 Protein Coding STEAP3 STEAP3 Metalloreductase Protein Coding ACSL1 Acyl-CoA Synthetase Long Chain Family Member 1 Protein
    [Show full text]
  • Suppl. Fig. Legends
    Supplementary Figures. Supplementary Figure 1. Extent of lesions. a. Extent of smallest (dark gray), average (medium gray), and largest (light gray) lesions in animals treated as indicated 4 weeks after the induction of focal ischemia. b, Quantitation of lesion volume shows that neither treatment alters stroke volume (controls are shown for comparison and are from concurrently run animals reported in ref. 24). Supplementary Figure 2. Combinatorial treatment promotes axon rewiring on the intact side of the spinal cord. a. Low-power camera lucida drawing showing area in the cervical spinal cord contralateral to the undamaged hemisphere with BDA-labeled axon in close proximity to a ventral horn motorneuron in lamina IX. b, c. Photomicrograph (b) and camera lucida drawing (c) of labeled axon shown in a. Quantitation of BDA-labeled axons in lamina IX per mm in the cervical enlargement. *: Differences between groups significant at P < 0.05. Supplementary Figure 3. Sequence homology between the scrambled NEP1-40 peptide and myelin-associated glycoprotein (MAG). Top: Sequence of NEP1-40 and the scrambled peptide. Bottom: Alignment of the scrambled peptide and a region of MAG sharing 12/32 (37%) identities, and 17/32 (53%) positives. Gaps = 8/32 (25%). The probability of this similarity occurring by chance is estimated as 7 x 10-4 (PSI-BlastP of Scrambled NEP vs mouse NR databank at NCBI Blast). Zai et al., Suppl. Fig. 2 Supplementary Table 1 Stereotaxic coordinates for BDA injections Injection site Rostro-caudal Medio-lateral 1 0.12 -0.23 2 0.07 -0.18 3 0.02 -0.18 4 0.02 -0.39 5 -0.03 -0.29 6 -0.03 -0.15 7 -0.03 -0.41 8 -0.08 -0.23 9 -0.08 -0.31 10 -0.13 -0.25 11 -0.13 -0.33 12 -0.18 -0.23 13 -0.18 -0.31 14 -0.23 -0.23 15 -0.23 -0.31 16 -0.28 -0.25 17 -0.28 -0.33 18 -0.33 -0.31 Figures are in cm relative to Bregma Supplementary Table 2.
    [Show full text]
  • Calsequestrin: a Well-Known but Curious Protein in Skeletal Muscle Jin Seok Woo 1, Seung Yeon Jeong2,3,Jiheepark2,3,Junheechoi2,3 and Eun Hui Lee2,3
    Woo et al. Experimental & Molecular Medicine (2020) 52:1908–1925 https://doi.org/10.1038/s12276-020-00535-1 Experimental & Molecular Medicine REVIEW ARTICLE Open Access Calsequestrin: a well-known but curious protein in skeletal muscle Jin Seok Woo 1, Seung Yeon Jeong2,3,JiHeePark2,3,JunHeeChoi2,3 and Eun Hui Lee2,3 Abstract Calsequestrin (CASQ) was discovered in rabbit skeletal muscle tissues in 1971 and has been considered simply a passive Ca2+-buffering protein in the sarcoplasmic reticulum (SR) that provides Ca2+ ions for various Ca2+ signals. For the past three decades, physiologists, biochemists, and structural biologists have examined the roles of the skeletal muscle type of CASQ (CASQ1) in skeletal muscle and revealed that CASQ1 has various important functions as (1) a major Ca2+-buffering protein to maintain the SR with a suitable amount of Ca2+ at each moment, (2) a dynamic Ca2+ sensor in the SR that regulates Ca2+ release from the SR to the cytosol, (3) a structural regulator for the proper formation of terminal cisternae, (4) a reverse-directional regulator of extracellular Ca2+ entries, and (5) a cause of human skeletal muscle diseases. This review is focused on understanding these functions of CASQ1 in the physiological or pathophysiological status of skeletal muscle. Introduction membrane and have a transverse orientation with respect + + Generally, the Ca2 supply in intracellular Ca2 signals to the main axis of myofibrils. The conformational 2+ 2+ 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; consists of two Ca pools: internal Ca (in the endo- changes in DHPR due to the action potential subsequently + plasmic or sarcoplasmic reticulum (ER or SR)) and activate ryanodine receptor type 1 (RyR1, an internal Ca2 + extracellular Ca2 .
    [Show full text]
  • SUPPLEMENTARY DATA Supplementary Table 1. Characteristics of the Organ Donors and Human Islet Preparations Used for RNA-Seq
    SUPPLEMENTARY DATA Supplementary Table 1. Characteristics of the organ donors and human islet preparations used for RNA-seq and independent confirmation and mechanistic studies. Gender Age BMI Cause of death Purity (years) (kg/m2) (%) F 77 23.8 Trauma 45 M 36 26.3 CVD 51 M 77 25.2 CVD 62 F 46 22.5 CVD 60 M 40 26.2 Trauma 34 M 59 26.7 NA 58 M 51 26.2 Trauma 54 F 79 29.7 CH 21 M 68 27.5 CH 42 F 76 25.4 CH 30 F 75 29.4 CVD 24 F 73 30.0 CVD 16 M 63 NA NA 46 F 64 23.4 CH 76 M 69 25.1 CH 68 F 23 19.7 Trauma 70 M 47 27.7 CVD 48 F 65 24.6 CH 58 F 87 21.5 Trauma 61 F 72 23.9 CH 62 M 69 25 CVD 85 M 85 25.5 CH 39 M 59 27.7 Trauma 56 F 76 19.5 CH 35 F 50 20.2 CH 70 F 42 23 CVD 48 M 52 24.5 CH 60 F 79 27.5 CH 89 M 56 24.7 Cerebral ischemia 47 M 69 24.2 CVD 57 F 79 28.1 Trauma 61 M 79 23.7 NA 13 M 82 23 CH 61 M 32 NA NA 75 F 23 22.5 Cardiac arrest 46 M 51 NA Trauma 37 Abbreviations: F: Female; M: Male; BMI: Body mass index; CVD: Cardiovascular disease; CH: Cerebral hemorrhage.
    [Show full text]